These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34460421)

  • 21. Lassa fever: a new appraisal.
    Monath TP
    Niger Med J; 1973 Jul; 3(3):162-3. PubMed ID: 16366355
    [No Abstract]   [Full Text] [Related]  

  • 22. Lassa fever outbreak continues across Nigeria.
    Bagcchi S
    Lancet Infect Dis; 2020 May; 20(5):543. PubMed ID: 32359466
    [No Abstract]   [Full Text] [Related]  

  • 23. Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria.
    Buba MI; Dalhat MM; Nguku PM; Waziri N; Mohammad JO; Bomoi IM; Onyiah AP; Onwujei J; Balogun MS; Bashorun AT; Nsubuga P; Nasidi A
    Am J Public Health; 2018 Feb; 108(2):262-264. PubMed ID: 29267063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018.
    Ashcroft JW; Olayinka A; Ndodo N; Lewandowski K; Curran MD; Nwafor CD; Madubuike K; Bagnall H; Musa AS; Ahmad A; Akinpelu A; Adeleye A; Martin C; Akano A; Onoja M; Iniobong A; Ukponu W; Arinze C; Ilori E; Mba N; Gannon B; Ahumibe A; Ihekweazu C
    Emerg Infect Dis; 2022 May; 28(5):994-997. PubMed ID: 35226800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nigeria hit by unprecedented Lassa fever outbreak.
    Roberts L
    Science; 2018 Mar; 359(6381):1201-1202. PubMed ID: 29590055
    [No Abstract]   [Full Text] [Related]  

  • 26. Preventive practices by households against Lassa fever transmission in Ondo State, Southwest, Nigeria.
    Isere EE; Fatiregun AA; Omorogbe NE; Oluwole MT
    Pan Afr Med J; 2022; 43():176. PubMed ID: 36879638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge, Misperceptions, Preparedness, and Barriers towards Lassa Fever Control among Health Care Workers in a Tertiary Institution in Enugu, Nigeria.
    Ndu AC; Kassy WC; Ochie CN; Arinze-Onyia SU; Okeke TA; Aguwa EN; Okwor TJ; Chinawa A
    J Health Care Poor Underserved; 2019; 30(3):1151-1164. PubMed ID: 31422994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and case-control study of Lassa fever outbreak in Nigeria from 2018 to 2019.
    Ipadeola O; Furuse Y; Ilori EA; Dan-Nwafor CC; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Joseph G; Saleh M; Muwanguzi EN; Olayinka A; Namara G; Naidoo D; Iniobong A; Amedu M; Ugbogulu N; Makava F; Adeoye O; Uzoho C; Anueyiagu C; Okwor TJ; Mba NG; Akano A; Ogunniyi A; Mohammed A; Adeyemo A; Ugochukwu DK; Agogo E; Ihekweazu C
    J Infect; 2020 May; 80(5):578-606. PubMed ID: 31926184
    [No Abstract]   [Full Text] [Related]  

  • 31. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.
    Kakaī CG; Okunromade OF; Dan-Nwafor CC; Chabi AIB; Martial GTP; Dalhat MM; Ward S; Tante O; Nguku PM; Hamadi A; Ilori E; Lokossou V; Brito C; Ojo OE; Kone I; Agbeko TT; Ihekweazu C; Merrill RD
    Health Secur; 2020 Jan; 18(S1):S105-S112. PubMed ID: 32004125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.
    Grace JA; Egoh IJ; Udensi N
    Ther Adv Infect Dis; 2021; 8():20499361211058252. PubMed ID: 34868582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First confirmed diagnosis of Lassa fever in Kebbi state, northwest Nigeria: Lessons to be learned.
    Otubogun F; Tuko M; Sanni N
    Trop Doct; 2023 Jan; 53(1):7-8. PubMed ID: 36164684
    [No Abstract]   [Full Text] [Related]  

  • 35. Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria.
    Ijarotimi IT; Ilesanmi OS; Aderinwale A; Abiodun-Adewusi O; Okon IM
    Pan Afr Med J; 2018; 30():56. PubMed ID: 30197747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005-2008.
    Ehichioya DU; Asogun DA; Ehimuan J; Okokhere PO; Pahlmann M; Olschläger S; Becker-Ziaja B; Günther S; Omilabu SA
    Trop Med Int Health; 2012 Aug; 17(8):1001-4. PubMed ID: 22594713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks.
    Malik S; Bora J; Dhasmana A; Kishore S; Nag S; Preetam S; Uniyal P; Slama P; Mukherjee N; Haque S; Swed S
    Int J Surg; 2023 Mar; 109(3):584-586. PubMed ID: 37093095
    [No Abstract]   [Full Text] [Related]  

  • 39. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.